Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

1.

Can sudden cardiac death be prevented?

Maron BJ.

Cardiovasc Pathol. 2010 Nov-Dec;19(6):329-35. doi: 10.1016/j.carpath.2010.03.002. Epub 2010 Apr 8.

PMID:
20378375
[PubMed - indexed for MEDLINE]
2.

Sudden death in hypertrophic cardiomyopathy.

Maron BJ.

J Cardiovasc Transl Res. 2009 Dec;2(4):368-80. doi: 10.1007/s12265-009-9147-0. Epub 2009 Nov 13. Review.

PMID:
20559995
[PubMed - indexed for MEDLINE]
3.

Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy.

Maron BJ.

Circ J. 2010 Nov;74(11):2271-82. Epub 2010 Oct 16. Review.

PMID:
20962423
[PubMed - indexed for MEDLINE]
Free Article
4.

Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.

Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA 3rd, Spirito P.

N Engl J Med. 2000 Feb 10;342(6):365-73.

PMID:
10666426
[PubMed - indexed for MEDLINE]
Free Article
5.

Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.

Maron BJ.

Cardiol Rev. 2002 May-Jun;10(3):173-81. Review.

PMID:
12047795
[PubMed - indexed for MEDLINE]
6.

[Hypertrophic cardiomyopathy and sudden cardiac death--ICD indications in the margin of uncertainty].

Fauchère I, Duru F.

Praxis (Bern 1994). 2009 Aug 26;98(17):941-52. doi: 10.1024/1661-8157.98.17.941. Review. German.

PMID:
19711287
[PubMed - indexed for MEDLINE]
7.

Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.

Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.

Rev Port Cardiol. 2005 Mar;24(3):407-15. English, Portuguese.

PMID:
15929624
[PubMed - indexed for MEDLINE]
8.

Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy.

Maron BJ.

Curr Cardiol Rep. 2000 Nov;2(6):522-8. Review.

PMID:
11060579
[PubMed - indexed for MEDLINE]
9.

Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.

Bongioanni S, Spirito P, Masi AS, Chiribiri A, Bonamini R, Conte MR.

Circ Cardiovasc Imaging. 2009 Jul;2(4):349-50. doi: 10.1161/CIRCIMAGING.108.824839. No abstract available.

PMID:
19808616
[PubMed - indexed for MEDLINE]
Free Article
10.

Sudden death and hypertrophic cardiomyopathy: a review.

Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.

Can J Cardiol. 2005 Apr;21(5):441-8. Review.

PMID:
15861263
[PubMed - indexed for MEDLINE]
11.

Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.

Limongelli G, Elliott PM, Pacileo G, Sarubbi B, Thaman R, Calabrò P, Vergara P, Iacomino M, Russo MG, Calabrò R.

J Cardiovasc Med (Hagerstown). 2006 Sep;7(9):711-3.

PMID:
16932087
[PubMed - indexed for MEDLINE]
12.

Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Begley DA, Mohiddin SA, Tripodi D, Winkler JB, Fananapazir L.

Pacing Clin Electrophysiol. 2003 Sep;26(9):1887-96.

PMID:
12930505
[PubMed - indexed for MEDLINE]
13.

A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.

O'Mahony C, Tome-Esteban M, Lambiase PD, Pantazis A, Dickie S, McKenna WJ, Elliott PM.

Heart. 2013 Apr;99(8):534-41. doi: 10.1136/heartjnl-2012-303271. Epub 2013 Jan 22.

PMID:
23339826
[PubMed - indexed for MEDLINE]
14.

Management of hypertrophic cardiomyopathy in children.

Seggewiss H, Rigopoulos A.

Paediatr Drugs. 2003;5(10):663-72. Review.

PMID:
14510624
[PubMed - indexed for MEDLINE]
15.

Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.

Maron BJ, Spirito P.

J Cardiovasc Electrophysiol. 2008 Oct;19(10):1118-26. doi: 10.1111/j.1540-8167.2008.01147.x. Epub 2008 Mar 31. Review.

PMID:
18384577
[PubMed - indexed for MEDLINE]
16.

Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis.

Schinkel AF, Vriesendorp PA, Sijbrands EJ, Jordaens LJ, ten Cate FJ, Michels M.

Circ Heart Fail. 2012 Sep 1;5(5):552-9. Epub 2012 Jul 20. Review.

PMID:
22821634
[PubMed - indexed for MEDLINE]
Free Article
17.

[Interventional treatment in hypertrophic cardiomyopathy].

Gietzen FH, Schümmelfeder J, Neuser H, Brunn J, Schumacher B, Kerber S.

Herz. 2005 Mar;30(2):102-10. Review. German.

PMID:
15875098
[PubMed - indexed for MEDLINE]
18.

[Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM].

Maron BJ, Spirito P.

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr;37(4):297-302. Chinese.

PMID:
19791462
[PubMed - indexed for MEDLINE]
19.

Device therapy in hypertrophic cardiomyopathy.

Beadle R, Williams L.

Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1767-75. doi: 10.1586/erc.10.156. Review.

PMID:
21108558
[PubMed - indexed for MEDLINE]
20.

[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].

Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.

Rev Esp Cardiol. 2006 Jun;59(6):537-44. Spanish.

PMID:
16790196
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk